全文获取类型
收费全文 | 343篇 |
免费 | 15篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 22篇 |
妇产科学 | 6篇 |
基础医学 | 28篇 |
口腔科学 | 7篇 |
临床医学 | 36篇 |
内科学 | 53篇 |
皮肤病学 | 8篇 |
神经病学 | 8篇 |
特种医学 | 126篇 |
外科学 | 3篇 |
综合类 | 15篇 |
预防医学 | 18篇 |
眼科学 | 4篇 |
药学 | 15篇 |
1篇 | |
肿瘤学 | 5篇 |
出版年
2023年 | 2篇 |
2021年 | 6篇 |
2018年 | 2篇 |
2016年 | 10篇 |
2015年 | 14篇 |
2014年 | 5篇 |
2013年 | 7篇 |
2012年 | 11篇 |
2011年 | 9篇 |
2010年 | 7篇 |
2009年 | 7篇 |
2008年 | 5篇 |
2006年 | 2篇 |
2005年 | 4篇 |
2004年 | 3篇 |
2003年 | 4篇 |
2002年 | 3篇 |
1999年 | 5篇 |
1998年 | 19篇 |
1997年 | 22篇 |
1996年 | 20篇 |
1995年 | 17篇 |
1994年 | 14篇 |
1993年 | 13篇 |
1992年 | 3篇 |
1991年 | 4篇 |
1990年 | 6篇 |
1989年 | 12篇 |
1988年 | 18篇 |
1987年 | 15篇 |
1986年 | 11篇 |
1985年 | 12篇 |
1984年 | 3篇 |
1983年 | 2篇 |
1982年 | 2篇 |
1981年 | 7篇 |
1979年 | 2篇 |
1978年 | 7篇 |
1968年 | 2篇 |
1967年 | 4篇 |
1966年 | 2篇 |
1964年 | 2篇 |
1961年 | 2篇 |
1959年 | 4篇 |
1958年 | 4篇 |
1957年 | 3篇 |
1956年 | 4篇 |
1955年 | 2篇 |
1954年 | 3篇 |
1953年 | 2篇 |
排序方式: 共有359条查询结果,搜索用时 15 毫秒
81.
82.
MORGAN ANDERSSON NILS LINDQVIST CHRISTER SVENSSON LARS EK ULF PIPKORN 《Clinical otolaryngology》1993,18(1):30-33
Topical steroids are known to be effective in allergic inflammatory airway disease. However, progress in the treatment of these diseases has also called for the use of unadulterated drugs, without lubricants and preservatives. Rhinocort® Turbuhaler®, a multi-dose inhaler containing budesonide as a pure powder, is a newly developed device without any carrier gas, preservatives or lubricants. The efficacy and tolerance of this product were evaluated in 60 patients with birch pollen rhinitis. After a run-in period of 1 week the patients received once daily for 4 weeks either budesonide pure powder (400 μg) or placebo in a double-blind randomized fashion. Assessment of efficacy was made by comparing scores for different nasal and eye symptoms. The additional use of antihistamine tablets was assessed. In 22 of the patients nasal peak inspiratory flow rate was measured before and after 1 week of treatment. Budesonide was significantly more effective than placebo in controlling the nasal symptoms (P-values ranging from 0.011–0.045). The use of antihistamine tablets was significantly lower in the budesonide group (P= 0.012). The nasal inspiratory flow rate was increased after 1 week of treatment in the budesonide treated group of patients as compared with placebo (P= 0.007). No differences were observed between the groups with regard to eye symptoms or adverse effects. The results show that budesonide delivered from a dry powder inhaler is an effective and well tolerated treatment of seasonal allergic rhinitis. 相似文献
83.
84.
85.
Isha Patel Rachel Rarus Xi Tan EK Lee Jason Guy Akram Ahmad Jongwha Chang 《Indian journal of pharmacology》2015,47(6):585-593
Comparative effectiveness research (CER) is an important branch of pharmacoeconomics that systematically studies and evaluates the cost-effectiveness of medical interventions. CER plays instrumental roles in guiding government public health policy programs and insurance. Countries throughout the world use different methods of CER to help make medical decisions based on providing optimal therapy at a reduced cost. Expenses to the healthcare system continue to rise, and CER is one-way in which expenses could be curbed in the future by applying cost-effectiveness evidence to clinical decisions. China, India, South Korea, and the United Kingdom are of essential focus because these country''s economies and health care expenses continue to expand. The structures and use of CER are diverse throughout these countries, and each is of prime importance. By conducting this thorough comparison of CER in different nations, strategies and organizational setups from different countries can be applied to help guide public health and medical decision-making in order to continue to expand the establishment and role of CER programs. The patient-centered medical home has been created to help reduce costs in the primary care sector and to help improve the effectiveness of therapy. Barriers to CER are also important as many stakeholders need to be able to work together to provide the best CER evidence. The advancement of CER in multiple countries throughout the world provides a possible way of reducing costs to the healthcare system in an age of expanding expenses.KEY WORDS: Comparative effectiveness research, health care costs, pharmacoeconomics 相似文献
86.
Loss of bone mineral density in Chinese pre-menopausal women with systemic lupus erythematosus treated with corticosteroids 总被引:7,自引:1,他引:7
The adverse effect of disease and chronic corticosteroid therapy on bone
mineral density (BMD) in patients with systemic lupus erythematosus (SLE)
has been reported in several studies of Caucasian populations. As the
factors controlling bone homeostasis may be different in Asian populations,
we measured BMD in 52 pre-menopausal Chinese women (mean age 34.1 +/- 8.0
yr) with SLE (mean disease duration 6.4 +/- 4.5 yr) treated with prednisone
(mean daily dose 11.4 +/- 10.8 mg/day). Lumbar spine, hip (total and
subregions) and total body BMDs were measured in the SLE patients using
dual-energy X-ray absorptiometry (DEXA), and compared with those from
healthy controls matched for age, sex and body mass index. Compared to
controls, SLE patients were found to have lower BMD (g/cm2) at several
sites: the lumbar spine (0.98 vs 0.90, P = 0.001), Ward's triangle (0.72 vs
0.67, P = 0.03), total body (1.04 vs 1.01, P = 0.04) and total hip (0.87 vs
0.82, P = 0.05). There was no correlation between BMD at any region and
duration of disease, activity of disease or prednisone therapy (mean daily
dose, cumulative dose or treatment duration). When BMDs were compared
between controls and SLE patients, subgrouped according to those not on
calcium and those arbitrarily receiving calcium supplements (1 g/day),
significantly lower BMDs were found in those not on calcium compared to
both controls and SLE patients on calcium. BMDs in SLE patients on calcium
were not different from those in controls. The low prevalence of
osteoporosis in our SLE patients (4-6%) suggests significant loss of BMD in
Chinese SLE patients on corticosteroid therapy is less than that reported
in Caucasians (12-18%).
相似文献
87.
Nichols WC; Cooney KA; Mohlke KL; Ballew JD; Yang A; Bruck ME; Reddington M; Novak EK; Swank RT; Ginsburg D 《Blood》1994,83(11):3225-3231
An animal model for human type I von Willebrand disease (vWD) has been previously described in the inbred mouse strain RIIIS/J. Murine vWD is characterized by a prolonged bleeding time, normal von Willebrand factor (vWF) multimer distribution, autosomal dominant inheritance, and proportionately decreased plasma vWF antigen, ristocetin cofactor, and factor VIII (FVIII) activities. To study the molecular genetics of murine vWD, a portion of the vWF gene surrounding exon 28 was cloned, sequenced, and used to develop two informative DNA sequence polymorphisms for rapid genotyping by DNA polymerase chain reaction. RIIIS/J mice were crossed with PWK/Ph mice, an inbred line of Mus musculus musculus, and the F1 progeny backcrossed to the parental PWK/Ph strain. vWF antigen levels in F1 mice were not significantly different from the parental RIIIS/J strain but were markedly decreased compared with the parental PWK/Ph mice. Genetic linkage analysis of 104 backcross progeny showed no correlation between vWF antigen level and vWF genotype. These data indicate that murine vWD is caused by a defect at a novel genetic locus, distinct from the murine vWF gene. The distribution of vWF antigen levels among backcross progeny suggests the presence of one major dominant vWD gene in the RIIIS/J mouse with possible modifying contributions from one or more additional minor loci. These observations may provide new insights into the molecular basis and variable expressivity of human vWD. 相似文献
88.
89.
EF Druyts BS Rachlis VD Lima SS Harvard W Zhang EK Brandson SA Strathdee JSG Montaner RS Hogg 《HIV medicine》2009,10(5):274-281
Objectives
The aim of the study was to compare the risks of death among HIV‐infected patients on highly active antiretroviral therapy (HAART) in two proximate, yet distinct neighbourhoods: a neighbourhood with a high concentration of gay men, and a neighbourhood with a high concentration of injecting drug users.Methods
We compared the clinical and socioeconomic characteristics of HIV‐infected patients from the two neighbourhoods entering the British Columbia Centre for Excellence in HIV/AIDS Drug Treatment Program from 1 September 1997 to 30 November 2005, using contingency table statistics. Cox survival models and Kaplan–Meier methods were used to estimate the cumulative mortality rates. Results We found significant differences between patients from the two neighbourhoods for all socioeconomic variables. Patients in the neighbourhood with a high concentration of injecting drug users were more likely to be female, have a history of injecting drug use, have a less HIV‐experienced physician and be less adherent. Patients in the neighbourhood with a high concentration of gay men were more likely to have AIDS. Mortality was significantly higher for patients in the neighbourhood with a high concentration of injecting drug users [hazard ratio (HR) 3.01; 95% confidence interval (CI) 1.73, 5.24].Conclusions
A threefold increase was observed in the risk of death among HIV‐infected individuals on HAART in the neighbourhood with a high concentration of injecting drug users relative to the neighbourhood with a high concentration of gay men. The implications of this study should be assessed in similar HIV/AIDS epicentres. 相似文献90.
Ryan EK Man Muhammad B Sasongko Jie Jin Wang Ecosse L Lamoureux 《Clinical & experimental ophthalmology》2013,41(3):293-301
A protective, but inconsistent association between myopia and a decreased risk of diabetic retinopathy (DR) has been suggested in several studies. However, it is unclear whether the structural, or the refractive components of myopia; or both, is the main contributor to this protective relationship. This paper provides a comprehensive review of existing evidence on the association between myopia, and its structural (axial length [AL], anterior chamber depth [ACD]) and refractive (lens biometry and corneal curvature [CC]) components, with DR. 11 studies consisting of 7230 subjects from 1960 to April 2012, were reviewed. A longer AL was the only variable associated with a lower risk and severity of DR. Therefore, the available evidence suggests that AL is the main contributor to the protective influence of myopia on DR observed in earlier studies. Further investigations are now needed to determine the mechanisms by which AL protects against DR. 相似文献